Biogen has appointed Michael Parini as its new Chief Legal Officer, effective August 3, 2026. Parini will oversee the company's global legal and compliance functions, report directly to CEO Christopher Viehbacher, and join Biogen's executive leadership team. He brings more than two decades of biopharmaceutical leadership experience, most recently serving as CEO of Spur Therapeutics, and previously holding senior roles at Freeline Therapeutics, Vertex Pharmaceuticals, and Pfizer. Biogen stated the appointment is intended to strengthen its corporate affairs and strategic capabilities as it advances its growth strategy and pipeline. Shares of Biogen were trading up 1.62% at $195.05 following the announcement.
Biogen IncAppointment of new Chief Legal Officer strengthens corporate affairs and strategic capabilities, supporting growth strategy.
Pfizer Inc
Vertex Pharmaceuticals Inc